This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W. G.
Right arrow Articles by Lim, Y. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, W. G.
Right arrow Articles by Lim, Y. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2004, p. 1379-1381, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1379-1381.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Reduction in Glycopeptide Resistance in Vancomycin-Resistant Enterococci as a Result of vanA Cluster Rearrangements

Wee Gyo Lee,* Ji Young Huh, Sung Ran Cho, and Young Ae Lim

Department of Laboratory Medicine, Ajou University School of Medicine, Suwon, South Korea

Received 24 September 2003/ Returned for modification 5 November 2003/ Accepted 29 December 2003

The molecular characterization of five clinical isolates of vanA-containing vancomycin-resistant enterococci with altered resistance to glycopeptides was examined. One strain represented an IS1216V insertion accompanied by partial deletion of the reading frame of vanX following a transposition event. The other four strains represented IS1216V within the vanX-vanY intergenic region associated with deletion of vanY or vanZ.


* Corresponding author. Mailing address: Department of Laboratory Medicine, Ajou University Hospital, San 5, Wonchun-Dong, Paldal-Gu, Suwon 442-749, South Korea. Phone: 82-31-219-5785. Fax: 82-31-219-5778. E-mail: weegyo{at}ajou.ac.kr.


Antimicrobial Agents and Chemotherapy, April 2004, p. 1379-1381, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1379-1381.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Park, I. J., Lee, W. G., Shin, J. H., Lee, K. W., Woo, G. J. (2008). VanB Phenotype-vanA Genotype Enterococcus faecium with Heterogeneous Expression of Teicoplanin Resistance. J. Clin. Microbiol. 46: 3091-3093 [Abstract] [Full Text]  
  • Ergani-Ozcan, A., Naas, T., Baysan, B. O., Ogunc, D., Inan, D., Colak, D., Nordmann, P. (2008). Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. J Antimicrob Chemother 61: 1033-1039 [Abstract] [Full Text]  
  • Song, J.-H., Ko, K. S., Suh, J. Y., Oh, W. S., Kang, C.-I., Chung, D. R., Peck, K. R., Lee, N. Y., Lee, W. G. (2008). Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype. J Antimicrob Chemother 61: 838-844 [Abstract] [Full Text]  
  • Novais, C., Freitas, A. R., Sousa, J. C., Baquero, F., Coque, T. M., Peixe, L. V. (2008). Diversity of Tn1546 and Its Role in the Dissemination of Vancomycin-Resistant Enterococci in Portugal. Antimicrob. Agents Chemother. 52: 1001-1008 [Abstract] [Full Text]  
  • Naas, T., Fortineau, N., Snanoudj, R., Spicq, C., Durrbach, A., Nordmann, P. (2005). First Nosocomial Outbreak of Vancomycin-Resistant Enterococcus faecium Expressing a VanD-Like Phenotype Associated with a vanA Genotype. J. Clin. Microbiol. 43: 3642-3649 [Abstract] [Full Text]  
  • Ko, K. S., Baek, J. Y., Lee, J.-Y., Oh, W. S., Peck, K. R., Lee, N., Lee, W. G., Lee, K., Song, J.-H. (2005). Molecular Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from Korea. J. Clin. Microbiol. 43: 2303-2306 [Abstract] [Full Text]